Thrombin-JMI in TKA minimizes hemoglobin reduction but may not be cost effective
Use of bovine thrombin to reduce blood loss in primary total knee arthroplasty: a controlled randomized trialJ Arthroplasty. 2013 Sep;28(8):1278-81
Did you know you're eligible to earn 0.5 CME credits for reading this report? Click Here
80 osteoarthritic patients, aged 18 years and older, undergoing total knee arthroplasty were randomized to evaluate the efficacy of bovine thrombin (Thrombin-JMI), over 2 years, in improving blood loss parameters, total drain output, transfusion requirements, length of stay, bleeding related complications and Knee Society Scores (KSS), during and after surgery. The evidence presented in this study...
Learn about our AI Driven
High Impact Search Feature
The OE High Impact metric uses AI to determine the impact a study will have by considering the content of the article itself. Built using the latest advances of natural language processing techniques. OE High Impact predicts an article’s future number of citations than impact factor alone.Continue